Procaps Group, S.A Debt to Equity Ratio 2020-2023 | PROCF
Current and historical debt to equity ratio values for Procaps Group, S.A (PROCF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Procaps Group, S.A debt/equity for the three months ending September 30, 2023 was 0.00.
| Procaps Group, S.A Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-09-30 |
$0.46B |
$0.04B |
11.97 |
| 2023-06-30 |
$0.46B |
$0.03B |
14.32 |
| 2023-03-31 |
$0.44B |
$0.01B |
84.46 |
| 2022-12-31 |
$0.46B |
$-0.00B |
-246.04 |
| 2022-09-30 |
$0.48B |
$-0.01B |
-45.82 |
| 2022-06-30 |
$0.50B |
$-0.03B |
-16.90 |
| 2022-03-31 |
$0.50B |
$-0.02B |
-25.58 |
| 2021-12-31 |
$0.50B |
$-0.04B |
-13.05 |
| 2021-09-30 |
$0.43B |
$0.04B |
11.80 |
| 2021-06-30 |
$0.17B |
$-0.03B |
-5.76 |
| 2021-03-31 |
$0.23B |
$-0.02B |
-9.64 |
| 2020-12-31 |
$0.61B |
$-0.26B |
-2.41 |
| 2020-09-30 |
$0.20B |
$0.01B |
39.48 |
| 2020-06-30 |
$0.20B |
$0.01B |
39.51 |
| 2020-03-31 |
$0.20B |
$0.01B |
39.51 |
| 2019-12-31 |
$0.20B |
$0.01B |
39.43 |
| 2019-09-30 |
$0.00B |
$0.00B |
23.60 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-03-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
